Skip to main content
. Author manuscript; available in PMC: 2016 Sep 10.
Published in final edited form as: Exp Cell Res. 2015 Jul 21;337(1):120–127. doi: 10.1016/j.yexcr.2015.07.017

Figure 5.

Figure 5

C/EPBδ was involved in SOCS3-enhanced inflammatory reactivities in IgG IC-treated macrophages. A, B, and C, indicated plasmids were transduced into RAW-Neo cells, and RAW-SOCS3 cells, respectively. 48 h later, the cells were treated with or without 100 μg/ml IgG IC for 4 h. Then cells were lysed and subjected to luciferase assays. Data were expressed as means ± S. E. M. (n=3, biological replicates). **, and *** indicated statistically significant difference— p < 0.01, and p < 0.001, respectively. D, RAW-Neo and RAW-SOCS3 cells were treated with or without 100 μg/ml IgG IC for 4 h. Then total proteins were extracted, and Western blot were performed by using rabbit anti-C/EBPδ antibody, and anti-GAPDH antibody, respectively. The level of GAPDH was shown at the bottom as a loading control.